Trials / Completed
CompletedNCT00699335
Matrifen® for Therapy of Severe Chronic Pain®
Efficacy of Matrifen® in Patients Older Than 18 Years With Severe, Chronic Pain Including Quality of Life Questionnaire
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,308 (actual)
- Sponsor
- Nycomed · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to evaluate the efficacy and safety of Matrifen® in patients with severe and chronic pain who could only be sufficiently treated with opioid analgetics (WHO class 3).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fentanyl | Fentanyl transdermal patch. This was an observational study - therefore, the physician decided about dosage according to individual needs |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-07-01
- First posted
- 2008-06-18
- Last updated
- 2012-05-08
- Results posted
- 2010-08-12
Locations
1,235 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00699335. Inclusion in this directory is not an endorsement.